The trademark application ENHANCED TARGET DRUG DELIVERY was filed by Vinci Pharmaceuticals, Inc., a U.S. corporation (the "Applicant"). Application refused.
The application was filed in English (German was selected as the second language).
The Refusal with reference B 018895241 was Rejected according to Article 7(1)(b) EUTMR with decision issued on November 28, 2023 by the EUIPO.
Goods And Services
The mark was filed in class 5 with pharmaceutical preparations for the treatment of retinal diseases.
The mark was filed in class 42 with research and development services in the field of retinal diseases and conducting clinical trials for others in the field of retinal disease..